- $2.07bn
- $2.04bn
- $69.23m
- 61
- 19
- 87
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 9 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17.6 | 13.4 | 0 | 15 | 69.2 |
Cost of Revenue | |||||
Gross Profit | 5.4 | 3.91 | 0 | 3.95 | 41.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18.6 | 15.2 | 41.7 | 60.8 | 98.7 |
Operating Profit | -0.957 | -1.79 | -41.7 | -45.8 | -29.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.986 | -0.649 | -44 | -70.5 | -64 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.814 | -0.439 | -43.4 | -70.2 | -64 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.814 | -0.439 | -94 | -90.8 | -73.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.814 | -0.439 | -94 | -91.6 | -74.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.38 | -0.217 | -0.537 | -0.766 | -0.349 |
Dividends per Share | |||||
Special Dividends per Share |